Gestational disease evaluation system

Abstract

The invention relates to a gestational disease evaluation system. Compared with the prior art, the gestational disease evaluation system comprises a sample acquisition module for acquiring genital tract secretion of a pregnant woman and preparing a secretion sample; a first detection module used for detecting the bacterial flora metabolism value of the sample; a sample screening module used for comparing the flora metabolism value of the sample with the reproductive tract flora metabolism value of a pre-stored standard population sample in a database and confirming the sample with a large comparison value difference; a second detection module used for performing microbial gene sequencing on samples with large contrast value differences; a sample processing module used for obtaining the flora structure characteristics of the sample and determining the number and the variety of microorganisms in the flora; a risk assessment module used for disease risk assessment; and an output execution module connected with the risk assessment module and used for providing a personalized treatment scheme. According to the gestational disease evaluation system provided by the invention, early prediction of occurrence of gestational diseases can be realized, intervention can be carried out, and the efficiency of guiding clinical treatment is improved.

Description

technical field [0001] This application relates to the field of disease assessment systems, and more specifically, relates to a pregnancy disease assessment system. Background technique [0002] Preeclampsia (pre-eclampsia, PE) is a serious pregnancy-specific disease, with an incidence rate of 2%-8%, and is the second leading cause of maternal and infant mortality. Preeclampsia generally occurs after 20 weeks of pregnancy. , the main clinical symptoms are high blood pressure, proteinuria, liver and kidney dysfunction, etc. Once diagnosed with preeclampsia, the child can only deliver as soon as possible, and there is no effective treatment. Gestational diabetes mellitus (GDM) is another pregnancy-specific disease, manifested as glucose intolerance in pregnant women, with an incidence rate of 5.2%-8.8% and an increasing trend year by year. Pregnant women with ketoacidosis, postpartum hemorrhage, fetal respiratory distress syndrome, malformation, premature birth, stillbirth, e...

AI Technical Summary

Problems solved by technology

Pregnancy-specific diseases seriously threaten the health of mothers and babies, but their etiology and pathogenesis are still unclear, and there is currently no recognized and effective prediction method, which severely limits the early prevention and diagnosis of the disease

[0003] At present, the evaluation of diseases during pregnancy is mostly carried out through blood sampling, which is invasive and requires multiple blood collections from pregnant women. The compliance of pregnant women is low, which affects the efficiency of guiding clinical diagnosis and treatment.

Images